Proposed Collection; 60-Day Comment Request Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development), 3160-3162 [2021-00636]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
3160
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
www.minorityhealth.hhs.gov.
Information about ACMH activities can
be found on the OMH website under the
heading About OMH, Committees and
Workgroups.
DATES: The ACMH meeting will be held
on Friday, January 29, 2021, from 1:30
p.m. to 2:00 p.m. ET. If the Committee
completes its work before 2:00 p.m., the
meeting will end early.
ADDRESSES: The meeting will be held
virtually and will be accessible by
webcast.
FOR FURTHER INFORMATION CONTACT:
Samuel Wu, Designated Federal Officer,
Advisory Committee on Minority
Health, Office of Minority Health,
Department of Health and Human
Services, Tower Building, 1101 Wootton
Parkway, Suite 100, Rockville,
Maryland 20852. Phone: 240–453–6173;
email: OMH-ACMH@hhs.gov.
SUPPLEMENTARY INFORMATION: In
accordance with Public Law 105–392,
the ACMH was established to provide
advice to the Deputy Assistant Secretary
for Minority Health on improving the
health of each racial and ethnic
minority group and on the development
of goals and specific program activities
of the OMH.
The purpose of the January 2021
ACMH meeting is to finalize
recommendations for improving access
to and utilization of clinical preventive
services among racial and ethnic
minority populations. The
recommendations will be given to the
Deputy Assistant Secretary for Minority
Health to inform efforts for removing
barriers to achieving health equity.
The meeting is open to the public.
Any individual who wishes to attend
the meeting must register by sending an
email to OMH-ACMH@hhs.gov by 5:00
p.m. ET on January 28, 2021. Each
registrant should provide name,
affiliation, phone number, and email
address. Registrants will receive
webcast access information via email.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
contact OMH-ACMH@hhs.gov and
reference this meeting. Requests for
special accommodations should be
made at least ten (10) business days
prior to the meeting.
Members of the public will have an
opportunity to provide comments at the
meeting. Public comments will be
limited to two minutes per speaker
during the time allotted. Individuals
who would like to submit written
statements should email OMH-ACMH@
hhs.gov at least five (5) business days
prior to the meeting.
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
Any members of the public who wish
to distribute electronic or printed
material(s) related to this meeting’s
topic to ACMH members should email
the Designated Federal Officer at OMHACMH@hhs.gov. The material should be
received by the Designated Federal
Officer at least five (5) business days
prior to the meeting.
[FR Doc. 2021–00576 Filed 1–13–21; 8:45 am]
Dated: January 11, 2021.
Samuel Wu,
Designated Federal Officer, Advisory
Committee on Minority Health.
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4150–29–P
Proposed Collection; 60-Day Comment
Request Data and Specimen Hub
(DASH) (Eunice Kennedy Shriver
National Institute of Child Health and
Human Development)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
National Institutes of Health
ACTION:
National Institute on Drug Abuse;
Notice of Closed Meeting
SUMMARY:
[FR Doc. 2021–00660 Filed 1–13–21; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Interventions to Prevent Electronic Nicotine
Delivery Systems (ENDS) Use Among
Adolescents (R01—Clinical Trial Optional).
Date: March 10, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Yvonne Owens Ferguson,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892,
(301) 402–7371, yvonne.ferguson@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
National Institutes of Health,
HHS.
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD), the National
Institutes of Health will publish
periodic summaries of propose projects
to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Regina Bures, Ph.D., Eunice
Kennedy Shriver National Institute of
Child Health and Human Development
(NICHD), National Institutes of Health,
6710B Rockledge Drive, Room 2160,
Bethesda, MD 20817, or call non-tollfree number (301) 496–9485 or Email
your request, including your address to:
NICHD.DASH@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
E:\FR\FM\14JAN1.SGM
14JAN1
3161
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: Data and
Specimen Hub (DASH)-0925–0744
expiration date 01/31/2022, REVISION,
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD), National
Institutes of Health (NIH).
Need and Use of Information
Collection: This is a request to revise the
previously approved submission (OMB
number: 0925–0744) to add the
collection of additional information
from Users who will submit information
to NICHD Data and Specimen Hub
(DASH) about studies, and data
collections stored in publicly accessible
external archives—a process hereinafter
referred to as ‘cataloging’ in DASH.
DASH has been established by NICHD
as a data sharing mechanism for
biomedical research investigators. It
serves as a centralized resource for
investigators to share and access deidentified study data from studies
funded by NICHD. DASH also serves as
a portal for requesting biospecimens
from selected DASH studies.
NICHD also supports other public
archives, data collections, and
resources, such as Data Sharing for
Demographic Research (DSDR), NICHD/
DIPHR Biospecimen Repository Access
and Data Sharing (BRADS), the Down
Syndrome Registry (DS-Connect),
Zebrafish Information Network (ZFIN),
etc. In addition to these NICHD-funded
public archives, many collaborative
studies funded through NICHD are
dispersed across other National
Institutes of Health (NIH) designated
archives, including the National Heart,
Lung, and Blood Institute (NHLBI)
Biologic Specimen and Data Repository
information about the studies and data
collections without creating an account.
Users who wish to submit studies or
request data stored in DASH, and/or
request biospecimens (stored in NICHD
contracted Biorepository) must register
for an account; Users who wish to
submit a study catalog and/or data
collection catalog must also register for
an account.
Information will be collected from
those wishing to create an account,
sufficient to identify them as unique
Users. Those submitting or requesting
data and/or biospecimens will be
required to provide additional
supporting information to ensure proper
use and security of NICHD DASH study
data and biospecimens. The information
collected is limited to the essential data
required to ensure the management of
Users in NICHD DASH is efficient and
the sharing of data and biospecimens
among investigators is effective. The
primary uses of the information
collected from Uses by NICHD will be
to:
• Communicate with the Users
regarding data submission, study catalog
submission, data collection catalog
submission, data requests and
biospecimen requests;
• Monitor data submissions, study
catalog submission, data collection
catalog submission, data requests and
biospecimen requests;
• Notify interested Users of updates
to data and biospecimen inventories
stored in NICHD DASH; and
• Help NICHD understand the use of
NICHD DASH study data and
biospecimen inventories by the research
community.
All the data collected from use of
NICHD DASH except for information
provided in the annual progress reports
are for the purposes of internal
administrative management of NICHD
DASH. Information gathered through
the annual progress reports may be used
in publications describing performance
of the DASH system.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
211.
Information Coordinating Center
(BioLINCC), and other NIH-wide
repositories, such as the Database of
Genotypes and Phenotypes (dbGaP).
In an effort to link these data
resources and increase the visibility of
NICHD-funded studies and data
collections, DASH will enable Users to
catalog studies and data collections
stored in other external archives to
facilitate their discovery through DASH.
Users submitting studies or data
collections for cataloging in DASH will
provide descriptive information about
the study required to populate the Study
Overview Page in DASH. This
cataloging process closely mirrors the
existing study data submission process
in DASH; however, no study
documentation or data will be uploaded
to DASH. Requesters will be directed to
the external archive via a URL link to
obtain access to the data stored in the
external archives and resources.
The potential for public benefit to be
achieved through sharing study data
and/or biospecimen inventories through
DASH for secondary analysis is
significant. Additionally, the ability to
centralize information regarding where
to find, and how to access, studies, and
data collections funded by NICHD
stored across various public archives
(i.e., cataloged studies and data
collections) further helps to promote
information discovery and reuse of data.
NICHD DASH supports NICHD’s
mission to ensure that every person is
born healthy and wanted; that women
suffer no harmful effects from
reproductive processes; that all children
have the chance to achieve their full
potential for healthy and productive
lives, free from disease or disability; and
to ensure the health, productivity,
independence, and well-being of all
people through optimal rehabilitation.
Study data and biospecimen sharing
and reuse will promote testing of new
hypotheses from data and biospecimens
already collected, facilitate transdisciplinary collaboration, accelerate
scientific findings and enable NICHD to
maximize the return on its investments
in research.
Anyone can access NICHD DASH to
browse and view descriptive
khammond on DSKJM1Z7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of form
User Registration .............................................................................................
Data and Biospecimen Inventory Submissions ...............................................
Study Catalog Submission ..............................................................................
Data Collection Catalog Submission ...............................................................
Data Request ...................................................................................................
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Frequency of
response per
respondent
200
36
10
6
60
E:\FR\FM\14JAN1.SGM
1
1
1
1
1
14JAN1
Average time
per response
(in hours)
5/60
2
30/60
15/60
1
Total annual
burden hour
17
72
5
2
60
3162
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Type of form
Frequency of
response per
respondent
Average time
per response
(in hours)
Total annual
burden hour
Biospecimen Request ......................................................................................
Data Use Annual Progress Report ..................................................................
Biospecimen Use Annual Progress Report .....................................................
Institutional Certification Template ..................................................................
36
60
36
36
1
1
1
1
1
10/60
10/60
5/60
36
10
6
3
Total ..........................................................................................................
200
200
........................
211
Dated: January 5, 2021.
Jennifer M. Guimond,
Project Clearance Liaison, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, National Institutes of
Health.
[FR Doc. 2021–00636 Filed 1–13–21; 8:45 am]
Fishers Lane, Room 3G62A, Rockville, MD
20852, (240) 669–5069, lrust@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–00577 Filed 1–13–21; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–00575 Filed 1–13–21; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; A Solicitation of the
National Institutes of Health (NIH) and the
Centers for Disease Control and Prevention
(CDC) for Small Business Innovation
Research (SBIR) Contract Proposals (N01),
Topic 100.
Date: February 2, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G62A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Lynn Rust, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exploring Epigenomic or Non-Coding RNA
Regulation in the Development,
Maintenance, or Treatment of Chronic Pain
(R61/R33 Clinical Trial Optional).
Date: February 22, 2021.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
National Institute on Drug Abuse 301 North
Stonestreet Avenue Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Modular Budget Research Project Grant for
NIH Nurse Scientist Scholars.
Date: February 5, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Pages 3160-3162]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00636]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request Data and Specimen Hub
(DASH) (Eunice Kennedy Shriver National Institute of Child Health and
Human Development)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 to provide opportunity for public comment on proposed data
collection projects, the Eunice Kennedy Shriver National Institute of
Child Health and Human Development (NICHD), the National Institutes of
Health will publish periodic summaries of propose projects to be
submitted to the Office of Management and Budget (OMB) for review and
approval.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact: Regina
Bures, Ph.D., Eunice Kennedy Shriver National Institute of Child Health
and Human Development (NICHD), National Institutes of Health, 6710B
Rockledge Drive, Room 2160, Bethesda, MD 20817, or call non-toll-free
number (301) 496-9485 or Email your request, including your address to:
[email protected]. Formal requests for additional plans and
instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written comments and/or suggestions
from the public and affected agencies are invited to address one or
more of the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have
[[Page 3161]]
practical utility; (2) The accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the information to be collected;
and (4) Ways to minimize the burden of the collection of information on
those who are to respond, including the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology.
Proposed Collection Title: Data and Specimen Hub (DASH)-0925-0744
expiration date 01/31/2022, REVISION, Eunice Kennedy Shriver National
Institute of Child Health and Human Development (NICHD), National
Institutes of Health (NIH).
Need and Use of Information Collection: This is a request to revise
the previously approved submission (OMB number: 0925-0744) to add the
collection of additional information from Users who will submit
information to NICHD Data and Specimen Hub (DASH) about studies, and
data collections stored in publicly accessible external archives--a
process hereinafter referred to as `cataloging' in DASH.
DASH has been established by NICHD as a data sharing mechanism for
biomedical research investigators. It serves as a centralized resource
for investigators to share and access de-identified study data from
studies funded by NICHD. DASH also serves as a portal for requesting
biospecimens from selected DASH studies.
NICHD also supports other public archives, data collections, and
resources, such as Data Sharing for Demographic Research (DSDR), NICHD/
DIPHR Biospecimen Repository Access and Data Sharing (BRADS), the Down
Syndrome Registry (DS-Connect), Zebrafish Information Network (ZFIN),
etc. In addition to these NICHD-funded public archives, many
collaborative studies funded through NICHD are dispersed across other
National Institutes of Health (NIH) designated archives, including the
National Heart, Lung, and Blood Institute (NHLBI) Biologic Specimen and
Data Repository Information Coordinating Center (BioLINCC), and other
NIH-wide repositories, such as the Database of Genotypes and Phenotypes
(dbGaP).
In an effort to link these data resources and increase the
visibility of NICHD-funded studies and data collections, DASH will
enable Users to catalog studies and data collections stored in other
external archives to facilitate their discovery through DASH. Users
submitting studies or data collections for cataloging in DASH will
provide descriptive information about the study required to populate
the Study Overview Page in DASH. This cataloging process closely
mirrors the existing study data submission process in DASH; however, no
study documentation or data will be uploaded to DASH. Requesters will
be directed to the external archive via a URL link to obtain access to
the data stored in the external archives and resources.
The potential for public benefit to be achieved through sharing
study data and/or biospecimen inventories through DASH for secondary
analysis is significant. Additionally, the ability to centralize
information regarding where to find, and how to access, studies, and
data collections funded by NICHD stored across various public archives
(i.e., cataloged studies and data collections) further helps to promote
information discovery and reuse of data. NICHD DASH supports NICHD's
mission to ensure that every person is born healthy and wanted; that
women suffer no harmful effects from reproductive processes; that all
children have the chance to achieve their full potential for healthy
and productive lives, free from disease or disability; and to ensure
the health, productivity, independence, and well-being of all people
through optimal rehabilitation. Study data and biospecimen sharing and
reuse will promote testing of new hypotheses from data and biospecimens
already collected, facilitate trans-disciplinary collaboration,
accelerate scientific findings and enable NICHD to maximize the return
on its investments in research.
Anyone can access NICHD DASH to browse and view descriptive
information about the studies and data collections without creating an
account. Users who wish to submit studies or request data stored in
DASH, and/or request biospecimens (stored in NICHD contracted
Biorepository) must register for an account; Users who wish to submit a
study catalog and/or data collection catalog must also register for an
account.
Information will be collected from those wishing to create an
account, sufficient to identify them as unique Users. Those submitting
or requesting data and/or biospecimens will be required to provide
additional supporting information to ensure proper use and security of
NICHD DASH study data and biospecimens. The information collected is
limited to the essential data required to ensure the management of
Users in NICHD DASH is efficient and the sharing of data and
biospecimens among investigators is effective. The primary uses of the
information collected from Uses by NICHD will be to:
Communicate with the Users regarding data submission,
study catalog submission, data collection catalog submission, data
requests and biospecimen requests;
Monitor data submissions, study catalog submission, data
collection catalog submission, data requests and biospecimen requests;
Notify interested Users of updates to data and biospecimen
inventories stored in NICHD DASH; and
Help NICHD understand the use of NICHD DASH study data and
biospecimen inventories by the research community.
All the data collected from use of NICHD DASH except for
information provided in the annual progress reports are for the
purposes of internal administrative management of NICHD DASH.
Information gathered through the annual progress reports may be used in
publications describing performance of the DASH system.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 211.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Frequency of Average time
Type of form Number of response per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
User Registration............................... 200 1 5/60 17
Data and Biospecimen Inventory Submissions...... 36 1 2 72
Study Catalog Submission........................ 10 1 30/60 5
Data Collection Catalog Submission.............. 6 1 15/60 2
Data Request.................................... 60 1 1 60
[[Page 3162]]
Biospecimen Request............................. 36 1 1 36
Data Use Annual Progress Report................. 60 1 10/60 10
Biospecimen Use Annual Progress Report.......... 36 1 10/60 6
Institutional Certification Template............ 36 1 5/60 3
---------------------------------------------------------------
Total....................................... 200 200 .............. 211
----------------------------------------------------------------------------------------------------------------
Dated: January 5, 2021.
Jennifer M. Guimond,
Project Clearance Liaison, Eunice Kennedy Shriver National Institute of
Child Health and Human Development, National Institutes of Health.
[FR Doc. 2021-00636 Filed 1-13-21; 8:45 am]
BILLING CODE 4140-01-P
